Committed to a world WITHOUT Alzheimer’s disease.

Alzheimer’s Therapeutic Research Institute

We are dedicated to helping the nation and the world confront the problem of Alzheimer’s Disease (AD) by rigorously testing novel treatments and identifying reliable markers for early detection of the disease.

About Us

Take Action

How YOU Can Make an Impact

Here at ATRI we rely on our community to make a difference when it comes to advancing AD research. You can help be a part of that, whether through direct participation or supporting the Institute.

Participate in a Study

Donate to ATRI

We lead scientific advancements & understanding of Alzheimer’s disease.

Dr. Alois Alzheimer describes disease

Alzheimer’s Disease Cooperative Study (ADCS) launched. Funded by NIA and led by Leon Thal

Anti-Amyloid Treatment in Asymptomatic Alzheimer's study

ATRI founded as a San Diego Institute of USC

Alzheimer’s Clinical Trials Consortium (ACTC) formed. Funded by NIA and led by Aisen, Petersen and Sperling.

Aducanumab receives accelerated approval for treatment of Alzheimer’s disease

View Timeline

Neuroscience Translational Research Division

Led by Robert Rissman, the neuroscience translational research division is made up of core facilities for basic science and translational research that’s focused on identifying biomarkers and innovative early detection methods.

Learn more about the NTRD

How can YOU take action

You can help prevent Alzheimer’s. There are a number of ways to take action.

Donate

Participate